Solstice Neurosciences, Llc, A Subsidiary Of Us Worldmeds, Llc

This study tested a medication called MYOBLOC for adults who have troublesome drooling (sialorrhea) due to conditions like Parkinson's disease, stroke, or ALS. Over one year, 187 participants received repeated injections to see if it safely reduces drooling. The main goal was to …

This study looked at the safety of MYOBLOC, a botulinum toxin type B injection, in 502 adults with cervical dystonia (neck muscle spasms). Participants received injections and were monitored for side effects and immune response. The goal was to see if the treatment is safe and ho…

This study tested whether injections of MYOBLOC into the saliva glands can safely reduce drooling in people with Parkinson's disease. 54 participants received either the drug or a placebo. The main goal was to see if drooling frequency and severity improved four weeks after the i…

This study tested an injected medication called MYOBLOC to reduce troublesome drooling in 187 adults. Drooling can be a side effect of many health conditions. The treatment was injected directly into the salivary glands and was shown to safely decrease saliva production. The goal…